Bladder Cancer

Seuraa
Illustration of a doctor delivering the gemcitabine-releasing bladder implant Inlexzo during a procedure, symbolizing successful tumor clearance in bladder cancer treatment.
AI:n luoma kuva

Gemcitabine-releasing bladder implant clears tumors in 82% of BCG‑unresponsive cases in phase 2 trial

Raportoinut AI AI:n luoma kuva Faktatarkistettu

A catheter-delivered implant that slowly releases gemcitabine eliminated visible tumors in 82% of patients with BCG‑unresponsive, high‑risk non‑muscle‑invasive bladder cancer in a phase 2 study. More than half of responders remained cancer‑free for at least a year, and the device has since been approved by the FDA as Inlexzo for patients with carcinoma in situ who are ineligible for, or decline, bladder removal.

The death certificate of 'The Middle' actor Pat Finn confirms bladder cancer as his cause of death, following initial reports of his passing on December 22, 2025, at age 60. Obtained by TMZ, the document details a years-long battle with a bladder tumor, with no other significant conditions listed.

Tämä verkkosivusto käyttää evästeitä

Käytämme evästeitä analyysiä varten parantaaksemme sivustoamme. Lue tietosuojakäytäntömme tietosuojakäytäntö lisätietoja varten.
Hylkää